B&D White Capital Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Hold
600
0.07% 73
2026
Q1
$552K Sell
600
-72
-11% -$73K 0.07% 57
2025
Q4
$722K Sell
672
-200
-23% -$191K 0.08% 59
2025
Q3
$665K Buy
+872
New +$649K 0.09% 61

Other funds holding LLY

B&D White Capital Company's LLY Position: Q2 2026 in Review

B&D White Capital Company held its Eli Lilly (LLY) position steady in Q2 2026 at 600 shares worth $720K. The position accounts for 0.07% of the portfolio, ranked #73.

B&D White Capital Company first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $722K in Q4 2025. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • B&D White Capital Company held 600 shares of Eli Lilly worth $720K as of Q2 2026.
  • B&D White Capital Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.07% of B&D White Capital Company's portfolio in Q2 2026, its #73 holding.
  • B&D White Capital Company first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • B&D White Capital Company's Eli Lilly position peaked at $722K in Q4 2025.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on B&D White Capital Company's 13F filing for Q2 2026, filed 31 Jul 2026.